Bausch + Lomb's Q1 Likely Saw Revenue Tailwinds From ForEx, RBC Says

MT Newswires Live
Apr 24

Bausch + Lomb's (BLCO) Q1 likely saw revenue tailwinds from foreign exchange, continuing trends from Q4, RBC Capital Markets said in a Thursday note.

Broad currency strength, compared with the US dollar, is estimated to have yielded about a $40 million revenue benefit in Q1 and will likely add about $70 million for all of 2026, RBC said. The company's 2026 revenue guidance currently calls for a $30 million FX tailwind, RBC said.

Bausch + Lomb is set to report its Q1 results on April 29 and investors are expected to focus on the company's primary prescription for dry eye disease products, the investment firm added. RBC said investor concerns include Miebo's profitability in 2026 and Xiidra's net pricing improvement.

RBC has an outperform rating on Bausch + Lomb, with a $21 price target.

Price: 15.75, Change: -0.03, Percent Change: -0.19

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10